Australian Cannabis Producers Eye European Market, Especially Germany And France, Marijuana And Menstrual Pain Study Underway
Australian Cannabis Producers Eye European Market, Especially Germany And France, Marijuana And Menstrual Pain Study Underway
澳大利亞大麻股生產商瞄準歐洲市場，特別是德國和法國，正在進行大麻和經期疼痛的研究
As the European cannabis scene develops, cannabis growers in Australia are looking to seize the opportunity. Some Australian farmers are already signing multi-million dollar export deals.
隨着歐洲大麻市場的發展，澳大利亞的大麻種植者正在尋求抓住機會。一些澳大利亞農民已經簽署了數百萬美元的出口協議。
Australian Natural Therapeutics Group (ANTG) is focusing on Germany, which recently relaxed its cannabis laws. Among the most significant reforms is the regulation of medical marijuana similar to ibuprofen. ANTG has been exporting to Germany since 2020.
澳大利亞自然療法集團（ANTG）將重點放在德國，德國最近放寬了大麻法。最重要的改革之一是對類似於布洛芬的醫用大麻的監管。自2020年以來，ANTG一直在向德國出口。
Germany is considered a leader of the European medical marijuana market, accounting for $621 million of the total $821 million sales in 2023, writes ABC news.
美國廣播公司新聞寫道，德國被認爲是歐洲醫用大麻市場的領導者，在2023年8.21億美元的總銷售額中佔6.21億美元。
"Germany is definitely the key market with a 90 million-odd population and a fairly...
ANTG首席執行官馬特·坎特...
登入免費觀看全文
登入/註冊
資訊熱榜
更新時間